can semaglutide cause bone loss Type 2 diabetes: may help protect health GLP-1 drugs — including Ozempic
Description
Separate "companion" products from "replacement" products
Ozempic, the brand name for semaglutide, is a GLP-1 receptor agonist used to treat type 2 diabetes and, more recently, obesity
This leads to the loss of collagen elasticity and degradation, increase in cardiac interstitial and perivascular fibrosis and subsequently to a reduction of arterial and myocardial compliance (50, 51)
When you stack these approaches intelligently, the synergy is real
